Synaps Dx

0 followers

Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.

Employees

11-50

Links


Org chart

Frank Amato
President and CEO, Synaps Dx
Collapse
Kathryn Diskin
HR & Administrative Manager
John Harvey Saquilayan
Medical Laboratory Scientist - Team Lead
Madhu Rao
Commercial Development DISCERN (TM) Diagnostic Test for Alzheimer's Disease Detection

Teams

This company has no teams yet